First Time Loading...

Neuronetics Inc
NASDAQ:STIM

Watchlist Manager
Neuronetics Inc Logo
Neuronetics Inc
NASDAQ:STIM
Watchlist
Price: 3.83 USD -3.28% Market Closed
Updated: Apr 19, 2024

Intrinsic Value

STIM's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Neuronetics, Inc. commercial stage medical technology company, which engages in the designing, developing and marketing products for the patients suffering from psychiatric disorders. [ Read More ]

The intrinsic value of one STIM stock under the Base Case scenario is 4.87 USD. Compared to the current market price of 3.83 USD, Neuronetics Inc is Undervalued by 21%.

Key Points:
STIM Intrinsic Value
Base Case
4.87 USD
Undervaluation 21%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Neuronetics Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling STIM stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Neuronetics Inc

Provide an overview of the primary business activities
of Neuronetics Inc.

What unique competitive advantages
does Neuronetics Inc hold over its rivals?

What risks and challenges
does Neuronetics Inc face in the near future?

Has there been any significant insider trading activity
in Neuronetics Inc recently?

Summarize the latest earnings call
of Neuronetics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Neuronetics Inc.

Provide P/S
for Neuronetics Inc.

Provide P/E
for Neuronetics Inc.

Provide P/OCF
for Neuronetics Inc.

Provide P/FCFE
for Neuronetics Inc.

Provide P/B
for Neuronetics Inc.

Provide EV/S
for Neuronetics Inc.

Provide EV/GP
for Neuronetics Inc.

Provide EV/EBITDA
for Neuronetics Inc.

Provide EV/EBIT
for Neuronetics Inc.

Provide EV/OCF
for Neuronetics Inc.

Provide EV/FCFF
for Neuronetics Inc.

Provide EV/IC
for Neuronetics Inc.

Show me price targets
for Neuronetics Inc made by professional analysts.

What are the Revenue projections
for Neuronetics Inc?

How accurate were the past Revenue estimates
for Neuronetics Inc?

What are the Net Income projections
for Neuronetics Inc?

How accurate were the past Net Income estimates
for Neuronetics Inc?

What are the EPS projections
for Neuronetics Inc?

How accurate were the past EPS estimates
for Neuronetics Inc?

What are the EBIT projections
for Neuronetics Inc?

How accurate were the past EBIT estimates
for Neuronetics Inc?

Compare the revenue forecasts
for Neuronetics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Neuronetics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Neuronetics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Neuronetics Inc compared to its peers.

Compare the P/E ratios
of Neuronetics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Neuronetics Inc with its peers.

Analyze the financial leverage
of Neuronetics Inc compared to its main competitors.

Show all profitability ratios
for Neuronetics Inc.

Provide ROE
for Neuronetics Inc.

Provide ROA
for Neuronetics Inc.

Provide ROIC
for Neuronetics Inc.

Provide ROCE
for Neuronetics Inc.

Provide Gross Margin
for Neuronetics Inc.

Provide Operating Margin
for Neuronetics Inc.

Provide Net Margin
for Neuronetics Inc.

Provide FCF Margin
for Neuronetics Inc.

Show all solvency ratios
for Neuronetics Inc.

Provide D/E Ratio
for Neuronetics Inc.

Provide D/A Ratio
for Neuronetics Inc.

Provide Interest Coverage Ratio
for Neuronetics Inc.

Provide Altman Z-Score Ratio
for Neuronetics Inc.

Provide Quick Ratio
for Neuronetics Inc.

Provide Current Ratio
for Neuronetics Inc.

Provide Cash Ratio
for Neuronetics Inc.

What is the historical Revenue growth
over the last 5 years for Neuronetics Inc?

What is the historical Net Income growth
over the last 5 years for Neuronetics Inc?

What is the current Free Cash Flow
of Neuronetics Inc?

Financials

Balance Sheet Decomposition
Neuronetics Inc

Current Assets 93.8m
Cash & Short-Term Investments 59.7m
Receivables 18.7m
Other Current Assets 15.4m
Non-Current Assets 22m
PP&E 4.8m
Other Non-Current Assets 17.3m
Current Liabilities 19.8m
Accounts Payable 4.8m
Accrued Liabilities 12.4m
Other Current Liabilities 2.7m
Non-Current Liabilities 61.8m
Long-Term Debt 59.3m
Other Non-Current Liabilities 2.5m
Efficiency

Earnings Waterfall
Neuronetics Inc

Revenue
71.3m USD
Cost of Revenue
-19.6m USD
Gross Profit
51.7m USD
Operating Expenses
-82.3m USD
Operating Income
-30.6m USD
Other Expenses
365k USD
Net Income
-30.2m USD

Free Cash Flow Analysis
Neuronetics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

STIM Profitability Score
Profitability Due Diligence

Neuronetics Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROIC is Increasing
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
25/100
Profitability
Score

Neuronetics Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

STIM Solvency Score
Solvency Due Diligence

Neuronetics Inc's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average D/E
36/100
Solvency
Score

Neuronetics Inc's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

STIM Price Targets Summary
Neuronetics Inc

Wall Street analysts forecast STIM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STIM is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.

Lowest
Price Target
6.06 USD
58% Upside
Average
Price Target
7.14 USD
86% Upside
Highest
Price Target
8.4 USD
119% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

STIM Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

STIM Price
Neuronetics Inc

1M 1M
-10%
6M 6M
+248%
1Y 1Y
+76%
3Y 3Y
-65%
5Y 5Y
-75%
10Y 10Y
-86%
Annual Price Range
3.83
52w Low
1.05
52w High
4.81
Price Metrics
Average Annual Return 13.58%
Standard Deviation of Annual Returns 97.49%
Max Drawdown -95%
Shares Statistics
Market Capitalization 111.4m USD
Shares Outstanding 29 756 100
Percentage of Shares Shorted 0.37%

STIM Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Neuronetics Inc Logo
Neuronetics Inc

Country

United States of America

Industry

Health Care

Market Cap

111.4m USD

Dividend Yield

0%

Description

Neuronetics, Inc. commercial stage medical technology company, which engages in the designing, developing and marketing products for the patients suffering from psychiatric disorders. The company is headquartered in Malvern, Pennsylvania and currently employs 175 full-time employees. The company went IPO on 2018-06-28. The firm is focused on designing, developing, and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The firm intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The firm sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.

Contact

PENNSYLVANIA
Malvern
3222 Phoenixville Pike
+18776007555.0
https://neurostar.com/neuronetics/

IPO

2018-06-28

Employees

175

Officers

President, CEO & Director
Mr. Keith J. Sullivan
Executive VP, CFO & Treasurer
Mr. Stephen J. Furlong M.S.
Executive VP, GC, Chief Compliance Officer & Corporate Secretary
Mr. W. Andrew Macan
Senior VP of Operations & Quality
Mr. Rusty Page
Senior VP & Chief Marketing Officer
Ms. Lisa Metzner-Rosas
Senior VP & Chief Revenue Officer
Ms. Sara Grubbs
Show More
Senior Vice President of National Accounts
Mr. Rick Grubbs
Senior Vice President of R&D and Clinical
Mr. Cory S. Anderson
Show Less

See Also

Discover More
What is the Intrinsic Value of one STIM stock?

The intrinsic value of one STIM stock under the Base Case scenario is 4.87 USD.

Is STIM stock undervalued or overvalued?

Compared to the current market price of 3.83 USD, Neuronetics Inc is Undervalued by 21%.